Company profile for Innovation Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. Through ongoing research and drug development efforts, Innovation is focused on improving the clinical car...
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100 Cummings Center, Suite 151-B BEVERLY, MASSACHUSETTS 01915
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/06/21/2691932/0/en/Innovation-Pharmaceuticals-Provides-Update-on-U-S-Patent-Applications-Covering-Use-of-Brilacidin-in-Inflammatory-Bowel-Diseases-Coronaviruses-and-Fungal-Diseases.html

GLOBENEWSWIRE
21 Jun 2023

https://www.globenewswire.com/news-release/2023/06/05/2682097/0/en/Innovation-Pharma-Announces-BeaMed-Technologies-Breakthrough-in-Development-of-Fiber-Optic-Probes-for-StingRay-Laser-System-Paves-Way-for-Groundbreaking-Integration-Testing.html

GLOBENEWSWIRE
05 Jun 2023

https://www.globenewswire.com/news-release/2023/04/17/2647871/0/en/Innovation-Pharmaceuticals-Brilacidin-Antifungal-Research-Published-in-Nature-Communications.html

GLOBENEWSWIRE
17 Apr 2023

https://www.globenewswire.com/news-release/2023/03/15/2627577/0/en/Innovation-Pharmaceuticals-Announces-New-Antifungal-Testing-of-Brilacidin-by-NIH-NIAID-Affiliated-and-Other-Academic-Researchers.html

GLOBENEWSWIRE
15 Mar 2023
Innovation Pharmaceuticals Visits BeaMed
Innovation Pharmaceuticals Visits BeaMed

23 Feb 2023

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2023/02/23/2614221/0/en/Innovation-Pharmaceuticals-Visits-BeaMed-New-StingRay-Laser-System-for-Epilepsy-and-Brain-Tumors-Moving-Toward-FDA-Submission.html

GLOBENEWSWIRE
23 Feb 2023

https://www.globenewswire.com/news-release/2023/01/09/2585096/0/en/Innovation-Pharmaceuticals-Announces-BT-BeaMedical-Technologies-and-Shina-Systems-Ltd-Enter-into-a-Definitive-Strategic-Development-Agreement.html

GLOBENEWSWIRE
09 Jan 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Innovation Pharmaceuticals and get a quotation

Innovation Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Innovation Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty